Related Experiment Video

Updated: Apr 6, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K

Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis

Da Shang1, Qionghong Xie2, Xiaolin Ge3

  • 1Division of Nephrology, Huashan Hospital, Fudan University, 12 Wulumuqi Road (middle), Shanghai, 200040, China. sdshangda@163.com.

BMC Nephrology
|July 19, 2015
PubMed

Insights

Hyperphosphatemia is a key risk factor for coronary artery calcification progression in peritoneal dialysis patients. Managing serum phosphate levels is crucial for cardiovascular health in end-stage renal disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Coronary artery calcification (CAC) significantly increases cardiovascular mortality risk in end-stage renal disease (ESRD) patients.
  • Identifying modifiable risk factors for CAC progression is critical, especially in patients undergoing peritoneal dialysis (PD).

Purpose of the Study:

  • To identify modifiable risk factors associated with coronary artery calcification progression in patients on peritoneal dialysis.
  • To investigate the relationship between serum phosphate levels and CAC progression in this population.

Main Methods:

  • Observational cohort study including 207 adult PD patients with serial coronary artery calcification score (CaCS) measurements.
  • Multislice spiral computed tomography (MSCT) used for CaCS assessment over a follow-up of ≥6 months.
  • Binary logistic and multivariate linear regression analyses employed to identify risk factors for CAC progression and hyperphosphatemia.

Main Results:

  • Age and serum phosphate level were identified as independent risk factors for CAC progression.
  • Hyperphosphatemia correlated with elevated transferrin, serum albumin, and normalized protein catabolic rate (nPCR).
  • Hyperphosphatemia also associated with reduced hemoglobin, residual creatinine clearance (Ccr), and PD Ccr.

Conclusions:

  • Hyperphosphatemia is an independent predictor of CAC progression in PD patients.
  • Serum phosphate levels may be linked to dietary protein intake and PD adequacy.
  • Findings offer valuable insights for managing cardiovascular risk in ESRD patients on PD.
Abstract

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.7K

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.7K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
630
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
978
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
637